Revisit the year's top episodes of JAMA Network podcasts, which feature in-depth discussions about current ideas and innovations in medicine, science, and clinical practice.
MOST LISTENED AUDIO 2020 March 24, 2020 Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and AzithromycinChloroquine was shown to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug’s potential benefits and risks for COVID-19 patients is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto. August 13, 2020 Why Are We Still Talking About Hydroxychloroquine as a Treatment for COVID-19?The use of hydroxychloroquine as a treatment for COVID-19 serves as an example of what is wrong with medical information being widely disseminated before it is thoroughly vetted by peer review. David Juurlink, MD, PhD, from the University of Toronto summarizes the evidence base regarding hydroxychloroquine and COVID-19. April 8, 2020 Coronavirus (COVID-19) Update: Reusing Face Masks and N95 RespiratorsShortages of face masks and N95 respirators have forced clinicians and hospitals to reuse these normally disposable items. Ron Shaffer, PhD, former CDC PPE Research Branch Chief, discusses effective sterilization techniques and how to test that the equipment stays protective after sterilization. October 19, 2020 Can We Count on Herd Immunity to Control COVID-19?Many people are hoping that enough people develop resistance to COVID-19, either from being exposed to the disease or from vaccination, to develop herd immunity that will enable society to return to normal. But will that happen? Saad Omer, MD, from the Yale Institute for Global Health, discusses his JAMA article on herd immunity and how much we can count on having it to return society to normal from this COVID-19 pandemic. March 16, 2020 COVID-19 in Seattle: Clinical Features and Managing the OutbreakJohn Lynch, MD, MPH, an infectious disease physician and medical director for infection prevention and control at the Harborview Medical Center, summarizes his hospital's experience managing the patients and outbreak. April 27, 2020 Pandemic Part 1: 1918 Flu Pandemic and COVID-19Medical historian Howard Markel, MD, PhD, director of the University of Michigan’s Center for the History of Medicine, speaks with JAMA Fishbein fellow Angel Desai, MD, about lessons from the devastating 1918 flu pandemic. Markel discusses his research into the effects of social distancing on US death rates during the worldwide outbreak. Pandemic Part 2: A Trip to Philadelphia’s Mutter Museum March 23, 2020 Coronavirus (COVID-19) Update: Early Safety Signals Around Ibuprofen and Renin-Angiotensin InhibitorsEmerging information about how SARS-CoV-2 virus infects cells has led to speculation that NSAIDs and ACE inhibitors/angiotensin receptor blockers (ARBs) may worsen clinical disease. Infectious disease physician Carlos del Rio, MD, of Emory University explains the concerns and their clinical implications. April 24, 2020 Coronavirus (COVID-19) Update: Ventilatory Management for COVID-Related Respiratory FailureManagement of COVID-19-related respiratory failure differs from what is necessary for ARDS. Ventilatory support for COVID-19 patients requires higher than normal tidal volumes with minimal PEEP and allowance for higher than usual serum CO2 levels. How the unique pathophysiology of respiratory failure should be treated is discussed by John J. Marini, MD, professor of medicine at the University of Minnesota. April 3, 2020 Coronavirus (COVID-19) Update: Safe Shopping at Stores and PharmaciesFood and medicine shopping is essential during the COVID-19 pandemic, but requires getting out and standing close to strangers at a time when social distancing and sheltering-in-place are recommended. David Aronoff, MD, director of the Division of Infectious Diseases at Vanderbilt University in Nashville, explains how to minimize COVID-19 risk while shopping. January 30, 2020 Dr Anthony Fauci: What Clinicians Need to Know About CoronavirusA new virus known as the 2019 novel coronavirus (2019-nCoV) is rapidly spreading through China. The rapid spread and severity of this illness are worrisome and the possibility that it develops into a pandemic is very real. Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, provides an update on this new disease. March 6, 2020 Update on Coronavirus: March 6, 2020, by NIAID’s Anthony Fauci, MDCoronovirus continues to spread throughout the world. Anthony Fauci, MD, is the director of the National Institute for Allergy and Infectious Diseases (NIAID) and has been the main spokesperson for the US government about SARS-CoV-2. Dr Fauci spoke with JAMA Editor in Chief Howard Bauchner, MD, about where we are as of today with the epidemic. July 13, 2020 How Is COVID-19 Transmitted?Whether the SARS-CoV-2 virus is transmitted by droplets or aerosol influences which public health interventions might slow its spread. Michael Klompas, MD, professor of medicine at Harvard Medical School, explains evidence to date about mechanisms of coronavirus transmission and implications for pandemic containment and mitigation efforts.
Michele Matucheski & Kellee Selden |
No comments:
Post a Comment